NEW YORK--(BUSINESS WIRE)--Jul. 26, 2017--
Deutsche Bank today announced its appointment as depositary bank for the
non-capital raising sponsored Level I American Depositary Receipt
program of Merck KGaA, Darmstadt, Germany.
Merck KGaA, Darmstadt, Germany (OTC:MKKGY) is a leading science and
technology company in healthcare, life science and performance
materials, developing technologies in the areas of biopharmaceutical
therapies for cancer and multiple sclerosis, scientific research and
production systems, and liquid crystals for smartphones and LCD
televisions. In 2016, Merck KGaA, Darmstadt, Germany employed around
50,000 employees and generated sales of approximately €15.0 billion in
“We are pleased to have been appointed as depositary bank for Merck
KGaA, Darmstadt, Germany’s Sponsored Level I ADR program, an important
addition to our client portfolio of DAX 30 companies,” said Brian
Studdert, Global Head of Depositary Receipts at Deutsche Bank.
“Leveraging Deutsche Bank’s range of ADR services, we look forward to
working with Merck KGaA, Darmstadt, Germany to help grow the ADR program
and diversify the shareholder base.”
In addition to specializing in administering cross-border equity
structures such as American and Global Depositary Receipts, Deutsche
Bank provides corporates, financial institutions, hedge funds and
supranational agencies around the world with trustee, agency, escrow and
related services. The Bank offers a very broad range of services for
diverse products, from complex securitizations and project finance to
syndicated loans, debt exchanges and restructurings.
* This information provided by Merck KGaA, Darmstadt, Germany (July
About Deutsche Bank:
Deutsche Bank provides commercial and investment banking, retail
banking, transaction banking and asset and wealth management products
and services to corporations, governments, institutional investors,
small and medium-sized businesses, and private individuals. Deutsche
Bank is Germany’s leading bank, with a strong position in Europe and a
significant presence in the Americas and Asia Pacific.
The Depositary Receipts have been registered pursuant to the US
Securities Act of 1933 (the "Act"). The investment or investment service
which is the subject of this notice is not available to retail clients
as defined by the UK Financial Conduct Authority. This notice has been
approved and/or communicated by Deutsche Bank AG New York. The services
described in this notice are provided by Deutsche Bank Trust CompanyAmericas (Deutsche Bank) or by its subsidiaries and/or affiliates in
accordance with appropriate local registration and regulation. Deutsche
Bank is providing the attached notice strictly for information purposes
and makes no claims or statement, nor does it warrant or in any way
represent, as to the accuracy or completeness of the details contained
herein or therein. This announcement appears as a matter of record only.
Neither this announcement nor the information contained herein
constitutes an offer or solicitation by Deutsche Bank or any other
issuer or entity for the purchase or sale of any securities nor does it
constitute a solicitation to any person in any jurisdiction where
solicitation would be unlawful. No part of this notice may be copied or
reproduced in any way without the prior written consent of Deutsche
Bank. Past results are not an indication of future performance.
Copyright © July 2017 Deutsche Bank AG. All rights reserved.
View source version on businesswire.com:
Source: Deutsche Bank
For further information, please contact:
Deutsche Bank AG
& Media Relations
Lawton King, +1(212) 250-0622